The objective of this study is to identify the T cell receptor-ligand interactions important for cellular trafficking to the genital tract, and to determine whether functional antigen-specific CTLs can be directed to the cervix following vaccination. In the first part of their study, they will compare in non-vaccinated, HPV(-) and HPV (+) women, the phenotype (including homing receptor expression) of T cells from the cervix and peripheral blood. They will also examine adhesion molecule expression on cervical epithelium. In the second part of the study, they will measure changes in anti-HPV CTL effector frequency in peripheral blood and cervix of HPV+ women after receiving the BIOTOPE vaccine using a flow assay that measures IFN gamma production following in vitro culture of cells with the antigenic epitope of the vaccine. They will also determine whether HPV-specific CTLs obtained from the cervix are enriched within the population of peripheral blood T cells expressing either systemic or mucosal homing receptors after vaccination. Their hypothesis is that CTL precursors that express systemic homing receptors eventually migrate to mucosal tissue sites. Their goals are to obtain information about T cell trafficking to the genital tract and to evaluate the BIOTOPE vaccine to induce CTL's within the cervix.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Exploratory/Developmental Grants (R21)
Project #
5R21CA081541-02
Application #
2896788
Study Section
Special Emphasis Panel (ZRG5-AARR-2 (03))
Program Officer
Wong, May
Project Start
1998-09-30
Project End
2001-09-30
Budget Start
1999-09-30
Budget End
2001-09-30
Support Year
2
Fiscal Year
1999
Total Cost
Indirect Cost
Name
Brigham and Women's Hospital
Department
Type
DUNS #
071723621
City
Boston
State
MA
Country
United States
Zip Code
02115